Schedule 13G ownership disclosure
BioAge Labs Inc
Common Stock, par value $0.00001 per share · CUSIP: 09077V100
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 1,310,589.00 · Class: 3.7%
- Peter Kolchinsky
Shares: 1,310,589.00 · Class: 3.7%
- Rajeev Shah
Shares: 1,310,589.00 · Class: 3.7%
- RA Capital Healthcare Fund, L.P.
Shares: 982,942.00 · Class: 2.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-004265
- Form type
- SCHEDULE 13G/A
- Filer
- BioAge Labs, Inc.
- CIK
- CIK 1709941
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership